Larvol Launches AI-Powered Cancer Data Platform During ASCO 2020
The Larvol Group on Monday announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting.
Pharmaceuticals, Biotechnology and Life Sciences
The Larvol Group on Monday announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting.
Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19.
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes high quality in vivo services for biotechs, pharmaceutical companies and academics.
The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about testing:
Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, is preparing to open its Technology Excellence Center in Boston (US TEC), Massachusetts.
LONDON–(BUSINESS WIRE)–#AlprazolamMarket–The alprazolam market is poised to grow by USD 90.33 million during 2020-2024, progressing at a CAGR of over…
Request FREE Proposal for Comprehensive Insights LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions…
NAARDEN, Netherlands & HERZLIYA, Israel–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative…
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Diana McKenzie has been appointed to its board of directors as…
– European approval is based on the Phase 3 BEACON CRC trial that demonstrated a significant improvement in overall survival…